Delivery Order SPE2DB22D1002-SPE2DB24FKXL7

Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a pharmaceutical product, specifically the TENIVAC SYRINGE 0.5ML, at a ceiling value of $1,085.45. This contract has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received the award as a single award indefinite delivery contract...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TENIVAC syringes. This $2,170.90 contract has a completion date of February 26, 2024 and will support U.S. military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. The company holds an indefinite delivery contract (IDC) with...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TENIVAC SYRINGE 0.5ML. The potential value of this award is $2,170.90 and the period of performance runs through February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Additionally, Amerisourcebergen Drug Corp holds an Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TENIVAC VIAL 0.5ML pharmaceutical product. The contract has a potential value of $1,992.90 and a performance period through January 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to DLA Troop Support Medical facilities in support of military treatment programs....
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 0.5 mL TENIVAC syringes. The contract, valued at $6,840.32, has a completion date of May 10, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $1,085.45 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564484054 TENIVAC SYRINGE 0.5ML medical supplies. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,239.24 contract is for the delivery of TENIVAC Syringe 0.5ML medical supplies to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TENIVAC SYRINGE 0.5ML. The $6,078.52 award has a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor for DLA Troop Support Medical, providing pharmaceuticals, medical supplies, and distribution services. This order is part of Amerisourcebergen's existing...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,270.10, is for the procurement of TENIVAC SYRINGE 0.5ML medical supplies. The contract has a firm fixed-price pricing type and a period of performance through March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TENIVAC SYRINGE 0.5ML. The contract has a firm fixed price of $4,171.55 and an ultimate completion date of August 1, 2024. The contract is not set aside for any socioeconomic program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FKXL7
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TENIVAC SYRINGE 0.5ML. The contract has a potential value of $2,844.05 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order, which is not associated with any set-aside program. The contract falls under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/3/24, 9:57 AM